Raltegravir and Liver injury - a phase IV clinical study of FDA data


Liver injury is found among people who take Raltegravir, especially for people who are female, 30-39 old.

The phase IV clinical study analyzes which people take Raltegravir and have Liver injury. It is created by eHealthMe based on reports of 4,255 people who have side effects when taking Raltegravir from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 30, 2023

4,255 people reported to have side effects when taking Raltegravir.
Among them, 6 people (0.14%) have Liver injury.

What is Raltegravir?

Raltegravir has active ingredients of raltegravir. eHealthMe is studying from 4,259 Raltegravir users for its effectiveness, alternative drugs and more.

What is Liver injury?

Liver injury is found to be associated with 1,651 drugs and 990 conditions by eHealthMe.

Number of Raltegravir and Liver injury reports submitted per year:

Could Raltegravir cause Liver injury?

Gender of people who have Liver injury when taking Raltegravir *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Liver injury when taking Raltegravir *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 33.33 %
  • 30-39: 66.67 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Raltegravir *:

  1. Truvada: 4 people, 66.67%
  2. Triumeq: 4 people, 66.67%
  3. Tivicay: 4 people, 66.67%
  4. Descovy: 4 people, 66.67%
  5. Pyridoxine: 2 people, 33.33%
  6. Sirturo: 1 person, 16.67%

Common side effects people have besides Liver injury *:

  1. Weakness: 4 people, 66.67%
  2. Thyrotoxic Crisis (a life threatening condition due to excess secretion of thyroid hormone): 4 people, 66.67%
  3. Acute Kidney Failure: 4 people, 66.67%
  4. Alanine Aminotransferase Increased: 4 people, 66.67%
  5. Aspartate Aminotransferase Increased: 4 people, 66.67%
  6. Bleeding Disorders: 4 people, 66.67%
  7. Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 4 people, 66.67%
  8. Circulatory Collapse: 4 people, 66.67%
  9. Disturbance In Attention: 4 people, 66.67%
  10. Drug-Induced Liver Injury (diseases of the liver that are caused by physician-prescribed medications): 4 people, 66.67%

Common conditions people have *:

  1. Hiv Infection: 4 people, 66.67%
  2. Pulmonary Tuberculosis (lungs tuberculosis): 2 people, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Raltegravir and have Liver injury?

Check whether Liver injury is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Liver injury and when was it recovered:

Expand to all the drugs that have ingredients of raltegravir:

Alternative drugs to, pros and cons of Raltegravir:

Common Raltegravir side effects:

Browse all side effects of Raltegravir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Liver injury treatments and more:

COVID vaccines that are related to Liver injury:

Common drugs associated with Liver injury:

All the drugs that are associated with Liver injury:

Common conditions associated with Liver injury:

All the conditions that are associated with Liver injury:

How the study uses the data?

The study uses data from the FDA. It is based on raltegravir (the active ingredients of Raltegravir) and Raltegravir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: